A current look at nutraceuticals - Key concepts and future prospects

被引:53
作者
da Costa, Joao Pinto [1 ]
机构
[1] Univ Aveiro, CESAM, Dept Chem, P-3810193 Aveiro, Portugal
关键词
Nutraceuticals; Supplements; Nutrition; Health; Disease; INDUCED COGNITIVE IMPAIRMENT; INDUCED BONE LOSS; BETA-CAROTENE; ELLAGIC ACID; DIETARY-SUPPLEMENTS; FUNCTIONAL FOODS; SOY ISOFLAVONES; DOUBLE-BLIND; IN-VITRO; ANTIOXIDANT CAPACITY;
D O I
10.1016/j.tifs.2017.02.010
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Background: Nutraceuticals exist in a legal limbo and the existing legislative efforts remain confusing, complex and not harmonized throughout the many regions of the Globe. These compounds are believed to contribute to improvements in physical and/or mental health and to ameliorate or avoid disease or health-related conditions. However, the promised food and health revolution is yet to come. Although some of these compounds have been shown to improve health, similar claims made for others have not been unequivocally demonstrated. Scope and approach: Herein, we explore the different definitions of nutraceuticals, associated legal definitions and constraints, while evaluating some of the facts and fictions surrounding these compounds. Lastly, we speculate on how the industry can evolve and how nutraceuticals can, in fact, make good on their promised health benefits. Key findings and conclusions: The high value market potential has led government agencies to establish regulatory requirements for the design, testing and marketing of these products, though much remains unregulated. Biologically, the often contradictory available data are based on the fact that the beneficial effects of a given chemical, agent or substance when consumed in food does not automatically translate into an enhanced health effect if consumed in concentrated forms or in higher quantities. How the nutraceutical industry will respond to the current lack of knowledge of these compounds, increasing demands of regulatory agencies and to the growing awareness of the general audience may very well determine the evolution of the industry and, to some extent, the health of their customers. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:68 / 78
页数:11
相关论文
共 203 条
  • [1] Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial
    Adams, KF
    Lampe, PD
    Newton, KM
    Ylvisaker, JT
    Feld, A
    Myerson, D
    Emerson, SS
    White, E
    Potter, JD
    Lampe, JW
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (03) : 620 - 626
  • [2] Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin
    Alves, DS
    Pérez-Fons, L
    Estepa, A
    Micol, V
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 68 (03) : 549 - 561
  • [3] In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: A new potentiality for ellagitannin metabolites against cancer
    Angeles Nunez-Sanchez, Maria
    Karmokar, Ankur
    Gonzalez-Sarrias, Antonio
    Garcia-Villalba, Rocio
    Tomas-Barberan, Francisco A.
    Teresa Garcia-Conesa, Maria
    Brown, Karen
    Carlos Espin, Juan
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2016, 92 : 8 - 16
  • [4] [Anonymous], 2005, Codex Alimentarius Commission, V3rd
  • [5] [Anonymous], 2002, PHARMACOGNOSY
  • [6] [Anonymous], 2016, VITAMINS S, V2016
  • [7] [Anonymous], 2014, Morality and the market (Routledge Revivals): consumer pressure for corporate accountability
  • [8] Participation of lycopene and beta-carotene in carcinogenesis: Defenders, aggressors, or passive bystanders?
    Arab, L
    Steck-Scott, S
    Bowen, P
    [J]. EPIDEMIOLOGIC REVIEWS, 2001, 23 (02) : 211 - 230
  • [9] Arredondo F, 2015, BIOACTIVE NUTRACEUTICALS AND DIETARY SUPPLEMENTS IN NEUROLOGICAL AND BRAIN DISEASE: PREVENTION AND THERAPY, P229, DOI 10.1016/B978-0-12-411462-3.00025-4
  • [10] Bagchi D., 2015, GENOMICS PROTEOMICS